- Home
- POCI vs PYPD Comparison
POCI vs PYPD Comparison
Compare POCI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- PYPD
- Stock Information
- Founded
- POCI 1982
- PYPD 2008
- Country
- POCI United States
- PYPD Israel
- Employees
- POCI N/A
- PYPD N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PYPD Medical/Dental Instruments
- Sector
- POCI Health Care
- PYPD Health Care
- Exchange
- POCI Nasdaq
- PYPD Nasdaq
- Market Cap
- POCI 34.4M
- PYPD 30.1M
- IPO Year
- POCI N/A
- PYPD 2020
- Fundamental
- Price
- POCI $4.10
- PYPD $2.71
- Analyst Decision
- POCI
- PYPD Strong Buy
- Analyst Count
- POCI 0
- PYPD 2
- Target Price
- POCI N/A
- PYPD $10.50
- AVG Volume (30 Days)
- POCI 14.6K
- PYPD 14.1K
- Earning Date
- POCI 05-14-2025
- PYPD 05-07-2025
- Dividend Yield
- POCI N/A
- PYPD N/A
- EPS Growth
- POCI N/A
- PYPD N/A
- EPS
- POCI N/A
- PYPD N/A
- Revenue
- POCI $18,682,766.00
- PYPD N/A
- Revenue This Year
- POCI N/A
- PYPD N/A
- Revenue Next Year
- POCI N/A
- PYPD N/A
- P/E Ratio
- POCI N/A
- PYPD N/A
- Revenue Growth
- POCI N/A
- PYPD N/A
- 52 Week Low
- POCI $3.47
- PYPD $2.37
- 52 Week High
- POCI $6.90
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- POCI 36.81
- PYPD 42.15
- Support Level
- POCI $4.40
- PYPD $2.66
- Resistance Level
- POCI $4.65
- PYPD $2.97
- Average True Range (ATR)
- POCI 0.24
- PYPD 0.14
- MACD
- POCI -0.03
- PYPD -0.02
- Stochastic Oscillator
- POCI 0.12
- PYPD 8.86
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.